Edwards Lifesciences Overview
Edwards Lifesciences Target Price
Analysts' 12-month price predictions for EW.
Share Price
$77.52
Average Target Price
$75.00
3.3% downside
3.3% downside1 analysts in the last 4 months
High: $75 | Low: $75
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-25 | Canaccord GenuityWilliam Plovanic | $75 | 3.3% downside |  |
| 2025-01-29 | Stifel NicolausRick Wise | $90 |  16.1% upside | |
| 2025-01-08 | BernsteinLee Hambright | $74 | 4.5% downside | |
| 2024-12-05 | BernsteinLee Hambright | $72 | 7.1% downside | |
| 2024-12-05 | Truist FinancialRichard Newitter | $78 | 0.6% upside | |
| 2024-12-05 | Canaccord GenuityWilliam Plovanic | $68 | 12.3% downside | |
| 2024-10-30 | Goldman SachsDavid Roman | $80 | 3.2% upside | |
| 2024-10-30 | Bank of America SecuritiesTravis Steed | $75 | 3.3% downside | |
| 2024-10-28 | CitigroupJoanne Wuensch | $81 | 4.5% upside | |
| 2024-10-15 | Robert W. BairdDavid Rescott | $73 | 5.8% downside | |
| 2024-10-11 | Morgan StanleyPatrick Wood | $70 | 9.7% downside | |
| 2024-10-07 | Canaccord GenuityWilliam Plovanic | $66 | 14.9% downside | |
| 2024-09-18 | JefferiesMatthew Taylor | $70 | 9.7% downside | |
| 2024-09-13 | Truist FinancialRichard Newitter | $71 | 8.4% downside | |
| 2024-09-09 | BarclaysMatt Miksic | $80 | 3.2% upside | |
| 2024-09-09 | Wells FargoLarry Biegelsen | $80 | 3.2% upside | |
| 2024-07-31 | DaiwaNarumi Nakagiri | $72 | 7.1% downside | |
| 2024-07-30 | CitigroupJoanna Wuensch | $83 | 7.1% upside | |
| 2024-07-25 | Deutsche BankPito Chickering | $85 | 9.6% upside | |
| 2024-07-25 | OppenheimerSuraj Kalia | $90 | 16.1% upside | |
| 2024-07-25 | J.P. MorganRobbie Marcus | $72 | 7.1% downside | |
| 2024-07-25 | RBC CapitalShagun Singh | $85 | 9.6% upside | |
| 2024-07-25 | Stifel NicolausRick Wise | $70 | 9.7% downside | |
| 2024-07-25 | Piper SandlerAdam Maeder | $73 | 5.8% downside | |
| 2024-07-16 | Truist FinancialRichard Newitter | $110 | 41.9% upside | |
| 2024-05-30 | Goldman SachsDavid Roman | $107 | 38% upside | |
| 2024-05-14 | Deutsche BankPito Chickering | $103 | 32.9% upside | |
| 2024-04-15 | RBC CapitalShagun Singh | $101 | 30.3% upside | |
| 2024-04-11 | Mizuho SecuritiesAnthony Petrone | $105 | 35.4% upside | |
| 2024-03-18 | OppenheimerSuraj Kalia | $100 | 29% upside | |
| 2023-02-01 | Canaccord Genuity | $76 | 2% downside | |
| 2023-02-01 | Truist Financial | $86 | 10.9% upside | |
| 2023-01-06 | Morgan Stanley | $95 | 22.5% upside | |
| 2022-12-13 | Raymond James | $83 | 7.1% upside | |
| 2022-12-12 | Citigroup | $92 | 18.7% upside | |
| 2022-12-05 | Stifel NicolausRick Wise | $75 | 3.3% downside | |
| 2022-11-28 | RBC Capital | $105 | 35.4% upside | |
| 2022-10-28 | RBC CapitalShagun Singh Chadha | $118 | 52.2% upside | |
| 2022-07-30 | Truist FinancialRichard Newitter | $120 | 54.8% upside | |
| 2022-04-27 | Canaccord Genuity | $137 | 76.7% upside | |
| 2022-04-27 | Raymond James | $124 | 60% upside | |
| 2022-04-27 | RBC Capital | $135 | 74.1% upside | |
| 2022-04-27 | Leerink Partners | $138 | 78% upside | |
| 2022-04-06 | Evercore ISIVijay Kumar | $126 | 62.5% upside | |
| 2022-03-03 | Bank of America SecuritiesTravis Steed | $130 | 67.7% upside | |
| 2022-01-27 | Stifel NicolausRick Wise | $120 | 54.8% upside | |
| 2022-01-27 | Morgan StanleyCecilia Furlong | $136 | 75.4% upside | |
| 2022-01-27 | Leerink PartnersDanielle Antalffy | $130 | 67.7% upside | |
| 2022-01-26 | Deutsche BankPito Chickering | $113 | 45.8% upside | |
| 2022-01-07 | Credit SuisseMatt Miksic | $140 | 80.6% upside | |